Table: Daito - 9-MTH group results

Daito Pharmaceutical

13/04/2023 07:00

Apr 13 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Feb 28, 2023        Feb 28, 2022     May 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               34.57               33.58            44.00    
                   (+2.9 pct)                           (+1.2 pct)  
  Operating            4.11                5.65             4.50    
                   (-27.3 pct)         (+5.8 pct)       (-31.3 pct) 
  Recurring            4.08                5.79             4.60    
                   (-29.6 pct)         (+6.9 pct)       (-31.6 pct) 
  Net                  2.66                3.98             3.20    
                   (-33.1 pct)         (+7.5 pct)       (-31.5 pct) 
  EPS              184.98 yen          287.81 yen       222.72 yen  
  EPS Diluted      184.76 yen                                       
  Ann Div                               60.00 yen        60.00 yen  
  -Q2 div           30.00 yen           25.00 yen                   
  -Q4 div                               35.00 yen        30.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T